The Children's Hospital of Zhejiang University School of Medicine is the lead sponsor of 43 current clinical trials in our China register. 21 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Telitacicept, Infliximab and Ruxolitinib. The most-studied condition is Autoimmune Diseases.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
NCT07283315 · Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR
|
Phase EARLY_PHASE1 | Recruiting | 2025-12 | China |
|
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
NCT06691152 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
|
Phase 1 | Recruiting | 2024-10 | China |
|
Blinatumomab for CNI-Resistant/Intolerant SRNS in Children
NCT06607991 · ClinicalTrials.gov ↗ · CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent, Steriod Resistant Nephrotic Syndrome
|
Phase 1 | Recruiting | 2024-09 | China |
|
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
NCT07813208 · ClinicalTrials.gov ↗ · Acute Lymphoblastic Leukemia, Pediatric
|
Observational | Recruiting | 2025-08 | China |
|
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07233642 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
|
Phase 1 | Recruiting | 2025-11 | China |
|
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
NCT07507201 · ClinicalTrials.gov ↗ · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome
|
Phase EARLY_PHASE1 | Recruiting | 2026-04 | China |
|
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
NCT07305116 · ClinicalTrials.gov ↗ · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome
|
Phase 1 | Recruiting | 2025-12 | China |
|
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
NCT07490041 · ClinicalTrials.gov ↗ · Rheumatic Diseases, Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese), Systemic Lupus Erythematosus (SLE)
|
Phase EARLY_PHASE1 | Recruiting | 2026-03 | China |
|
Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
NCT06125405 · ClinicalTrials.gov ↗ · Nephrotic Syndrome in Children, Telitacicept
Drug: Telitacicept |
Phase 3 | Recruiting | 2023-11 | China |
|
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
NCT07586267 · ClinicalTrials.gov ↗ · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome
|
Phase EARLY_PHASE1 | Recruiting | 2026-05 | China |
|
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants
NCT06788470 · ClinicalTrials.gov ↗ · BPD - Bronchopulmonary Dysplasia
|
Phase 1/2 | Recruiting | 2024-08 | China |
|
Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children
NCT06628765 · ClinicalTrials.gov ↗ · Urinary Stone
|
Not applicable | Recruiting | 2024-10 | China |
|
The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma
NCT07452380 · ClinicalTrials.gov ↗ · Allergic Rhinitis Due to House Dust Mite
|
Observational | Recruiting | 2025-11 | China |
|
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
NCT06553898 · ClinicalTrials.gov ↗ · Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy
|
Phase 1 | Recruiting | 2024-08 | China |
|
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
NCT07113808 · ClinicalTrials.gov ↗ · Abdominal Neoplasm, Abdominal Injury, Ascites
|
Observational | Recruiting | 2024-09 | China |
|
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
NCT06539624 · ClinicalTrials.gov ↗ · Fabry Disease
|
Not applicable | Recruiting | 2024-10 | China |
|
Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE
NCT07352332 · ClinicalTrials.gov ↗ · Childhood-onset Systemic Lupus Erythematosus
|
Observational | Recruiting | 2025-09 | China |
|
Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
NCT07450872 · ClinicalTrials.gov ↗ · Cancer, Glioma, Leukemia (Both ALL and AML)
|
Observational | Recruiting | 2026-01 | China |
|
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
NCT06792799 · ClinicalTrials.gov ↗ · Autoimmune Diseases, Systemic Lupus Erthematosus, Multi-Drug Resistant Nephrotic Syndrome
|
Phase EARLY_PHASE1 | Recruiting | 2025-01 | China |
|
Comparison of Stent-Related Symptoms Between Anti-Reflux Stents and Standard DJ Stents in Children With Urolithiasis
NCT06569173 · ClinicalTrials.gov ↗ · Urolithiasis, Child, Only
|
Not applicable | Recruiting | 2024-08 | China |
|
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
NCT06934447 · ClinicalTrials.gov ↗ · CAR T Cell Therapy, Systemic Lupus Erythematosus, BCMA
|
Phase 1 | Recruiting | 2025-04 | China |
|
Xenon Therapy for Children With Autism Spectrum Disorder
NCT07435103 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder (ASD), Autism
|
Phase 1/2 | Not yet open | 2026-03 | China |
|
Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants
NCT07045844 · ClinicalTrials.gov ↗ · Very Preterm Infant, Necrotizing Enterocolitis (NEC)
|
Not applicable | Not yet open | 2026-03 | China |
|
Natural Course of Congenital Hydronephrosis in Infants Aged 0-6 Months
NCT07382570 · ClinicalTrials.gov ↗ · Congenital Hydronephrosis, UTD Grading System, Natural Progression
|
Observational | Not yet open | 2026-03 | China |
|
Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery
NCT07574463 · ClinicalTrials.gov ↗ · Congenital Heart Disease (CHD), Congenital Heart Disease in Children
|
Not applicable | Not yet open | 2026-12 | China |
|
AI for Newborn Metabolic Screening
NCT07368504 · ClinicalTrials.gov ↗ · Inherited Metabolic Disorders
|
Not applicable | Not yet open | 2027-01 | China |
|
Optical Motion Capture-Assisted Ultrasound for Pediatric ESWL
NCT07299032 · ClinicalTrials.gov ↗ · Pediatric Urolithiasis, Extracorporeal Shock Wave Lithotripsy, Optical Motion Capture
|
Not applicable | Not yet open | 2026-01 | China |
|
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children
NCT07424040 · ClinicalTrials.gov ↗ · Crohn's Diseases, Crohn's Disease in Pediatric Patient
Drug: Infliximab |
Not applicable | Not yet open | 2026-03 | China |
|
NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy
NCT07462299 · ClinicalTrials.gov ↗ · Childhood Acute Lymphoblastic Leukemia
|
Not applicable | Not yet open | 2026-02 | China |
|
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
NCT07499154 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Postoperative Pulmonary Complications, Acute Lung Injury
|
Phase 4 | Not yet open | 2026-04 | China |
|
Dexamethasone Regimens for BPD Prevention in Preterm Infants
NCT07052201 · ClinicalTrials.gov ↗ · Infant, Premature, Bronchopulmonary Dysplasia (BPD)
|
Phase 3 | Not yet open | 2026-02 | China |
|
Exergame-Based Physical Activity Promotion for Children and Adolescents With Congenital Heart Disease
NCT07593118 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Physical Inactivity
|
Not applicable | Not yet open | 2026-07 | China |
|
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
NCT07298928 · ClinicalTrials.gov ↗ · Effectiveness
Drug: Telitacicept |
Not applicable | Not yet open | 2026-03 | China |
|
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
NCT07483749 · ClinicalTrials.gov ↗ · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma
|
Observational | Not yet open | 2026-03 | China |
|
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
NCT07674147 · ClinicalTrials.gov ↗ · Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis
|
Phase EARLY_PHASE1 | Not yet open | 2026-07 | China |
|
Urethral Plate Flap vs. Tunica Vaginalis Flap for Residual Severe Ventral Curvature in Hypospadias
NCT07404722 · ClinicalTrials.gov ↗ · Residual Severe Ventral Curvature, Transection of the Urethral Plate, Corporoplasty
|
Not applicable | Not yet open | 2026-02 | China |
|
Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo
NCT07595939 · ClinicalTrials.gov ↗ · Vitiligo
Drug: Ruxolitinib |
Phase 3 | Not yet open | 2026-06 | China |
|
Transcutaneous Tibial Nerve Stimulation Therapy in Children With Overactive Bladder
NCT06765629 · ClinicalTrials.gov ↗ · Overactive Bladder (OAB)
|
Not applicable | By invitation | 2024-03 | China |
|
Safety and Efficacy of AAV9. hMCOLN1co For Patients With Mucolipidosis Type IV
NCT07398872 · ClinicalTrials.gov ↗ · Mucolipidosis Type IV
|
Phase 1 | By invitation | 2026-01 | China |
|
Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children
NCT07549425 · Neuroblastic Tumors
|
Observational | Active, closed | 2026-01 | China |
|
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
NCT07437170 · ClinicalTrials.gov ↗ · Acute Myeloid Leukemia, Pediatric Acute Myeloid Leukemia, NUP98 Fusion-positive Acute Myeloid Leukemia
Drug: Selinexor |
Phase 2 | Active, closed | 2024-01 | China |
|
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus
NCT06222853 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus, CAR-T Cell Therapy
|
Phase 1 | Active, closed | 2024-02 | China |
|
Clinical Effectiveness of Non-contact Heart Rate and Respiratory Rate Monitoring System
NCT06573203 · ClinicalTrials.gov ↗ · Sleep, Infant，newborn, Vital Signs
|
Not applicable | Active, closed | 2024-08 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 43 | 21 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Essen Biotech | 2 |
| Adicet Therapeutics | 1 |
| Shanxi Bethune Hospital | 1 |
| The First Affiliated Hospital of University of Science and Technology of China | 1 |
| YANRU WANG | 1 |
Sponsors with the most current trials registered for this condition.
The Children's Hospital of Zhejiang University School of Medicine is the lead sponsor of 43 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 21 of its 43 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 4 drugs and biologicals as interventions. The most frequent are Telitacicept (2), Infliximab (1), Ruxolitinib (1) and Selinexor (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.